2008
DOI: 10.1016/j.biochi.2007.08.008
|View full text |Cite
|
Sign up to set email alerts
|

Emerging roles of ADAM and ADAMTS metalloproteinases in cancer

Abstract: A disintegrin and metalloproteinases (ADAMs) are a recently discovered family of proteins that share the metalloproteinase domain with matrix metalloproteinases (MMPs). Among this family, structural features distinguish the membrane-anchored ADAMs and the secreted ADAMs with thrombospondin motifs referred to as ADAMTSs. By acting on a large panel of membrane-associated and extracellular substrates, they control several cell functions such as adhesion, fusion, migration and proliferation. The current review add… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

5
175
0
8

Year Published

2009
2009
2022
2022

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 229 publications
(188 citation statements)
references
References 158 publications
5
175
0
8
Order By: Relevance
“…The finding that MMP-14 and -19 are unique to 21D1-Exos and not observed in our previously published MDCK/21D1 secretome analysis (24), may represent a mechanism that allows exosome-bound proteases to traffic and function at distant/metastatic sites. ADAM proteases contain MMP-like catalytic domains (83) and are important mediators of cell surface protein shedding during tumor progression (84). Interestingly, ADAM10 has been shown to be an active vesicle-based protease, cleaving cell adhesion molecule L1 at the cell surface, and subsequently promoting cell migration (85).…”
Section: Exosomes Contain Metastatic Niche Factors Following Oncogenimentioning
confidence: 99%
“…The finding that MMP-14 and -19 are unique to 21D1-Exos and not observed in our previously published MDCK/21D1 secretome analysis (24), may represent a mechanism that allows exosome-bound proteases to traffic and function at distant/metastatic sites. ADAM proteases contain MMP-like catalytic domains (83) and are important mediators of cell surface protein shedding during tumor progression (84). Interestingly, ADAM10 has been shown to be an active vesicle-based protease, cleaving cell adhesion molecule L1 at the cell surface, and subsequently promoting cell migration (85).…”
Section: Exosomes Contain Metastatic Niche Factors Following Oncogenimentioning
confidence: 99%
“…A disintegrins and metalloproteinases with thrombospondin motifs (ADAMTS), a family of extracellular metalloproteases, is structurally and functionally similar to matrix metalloproteinases (MMP) and ADAMs (7). Unlike ADAMs mainly as trans-membrane proteins, ADAMTSs are secreted proteinases binding to ECM (8). Dysregulated expression of ADAMTSs, such as ADAMTS1 (2), ADAMTS8, ADAMTS9 (5), ADAMTS12 (3), ADAMTS15 (4), ADAMTS18 (6), and ADAMTS20 (9,10), have been detected in diverse types of malignancies including lung, brain, breast, gastric, prostate, pancreatic cancers, and glioblastoma (8).…”
Section: Introductionmentioning
confidence: 99%
“…Unlike ADAMs mainly as trans-membrane proteins, ADAMTSs are secreted proteinases binding to ECM (8). Dysregulated expression of ADAMTSs, such as ADAMTS1 (2), ADAMTS8, ADAMTS9 (5), ADAMTS12 (3), ADAMTS15 (4), ADAMTS18 (6), and ADAMTS20 (9,10), have been detected in diverse types of malignancies including lung, brain, breast, gastric, prostate, pancreatic cancers, and glioblastoma (8). Various ADAMTSs have been shown to regulate cell proliferation, adhesion, migration, angiogenesis, and intracellular signaling (8,11), thus involved in multiple tumor pathogenesis (1,6).…”
Section: Introductionmentioning
confidence: 99%
“…However, the contribution of desmosomal cadherin regulation to epithelial remodeling via endocytic trafficking has not been addressed, nor is the involvement of RTKs or MMPs understood. The importance of RTKs and MMPs in epithelial remodeling processes is highlighted by the well-established role of erbB family members in tumor progression and recent recognition that ADAM family members are aberrantly expressed in certain cancers (Borrell-Pages et al, 2003;Rocks et al, 2008).…”
Section: Introductionmentioning
confidence: 99%